CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSchnell, Oliver
dc.contributor.authorBarnard\\-Kelly, Katharine
dc.contributor.authorBattelino, Tadej
dc.contributor.authorCeriello, Antonio
dc.contributor.authorLarsson, Helena Elding
dc.contributor.authorFernandez\\-Fernandez, Beatriz
dc.contributor.authorForst, Thomas
dc.contributor.authorFrias, Juan\\-Pablo
dc.contributor.authorGavin, James R.
dc.contributor.authorGiorgino, Francesco
dc.contributor.authorGroop, Per\\-Henrik
dc.contributor.authorHeerspink, Hiddo J. L.
dc.contributor.authorHerzig, Stephan
dc.contributor.authorHummel, Michael
dc.contributor.authorHuntley, George
dc.contributor.authorIbrahim, Mahmoud
dc.contributor.authorItzhak, Baruch
dc.contributor.authorJacob, Stephan
dc.contributor.authorJi, Linong
dc.contributor.authorKosiborod, Mikhail
dc.contributor.authorLalic, Nebosja
dc.contributor.authorMacieira, Sofia
dc.contributor.authorMalik, Rayaz A.
dc.contributor.authorMankovsky, Boris
dc.contributor.authorMarx, Nikolaus
dc.contributor.authorMathieu, Chantal
dc.contributor.authorMueller, Timo D.
dc.contributor.authorRay, Kausik
dc.contributor.authorRodbard, Helena W.
dc.contributor.authorRossing, Peter
dc.contributor.authorRyden, Lars
dc.contributor.authorSchumm\\-Draeger, Petra\\-Maria
dc.contributor.authorSchwarz, Peter
dc.contributor.authorSkrha, Jan
dc.contributor.authorSnoek, Frank
dc.contributor.authorTacke, Frank
dc.contributor.authorTaylor, Bruce
dc.contributor.authorJeppesen, Britta Tendal
dc.contributor.authorTesfaye, Solomon
dc.contributor.authorTopsever, Pinar
dc.contributor.authorVilsboll, Tina
dc.contributor.authorYu, Xuefeng
dc.contributor.authorStandl, Eberhard
dc.date.accessioned2025-10-16T15:13:37Z
dc.date.issued2024
dc.identifier.doi10.1186/s12933-024-02180-8
dc.identifier.otherWOS:001334087200001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5884
dc.publisherBMC
dc.sourceCARDIOVASCULAR DIABETOLOGY
dc.subjectCardiovascular disease
dc.subjectChronic kidney disease
dc.subjectCGM
dc.subjectDiabetes
dc.subjectFinerenone
dc.subjectGLP\\-1 RA
dc.subjectGuidelines
dc.subjectHeart failure
dc.subjectMASLD
dc.subjectNAFLD
dc.subjectObesity
dc.subjectSGLT2 inhibitor
dc.subjectTeplizumab
dc.titleCVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
dc.typeEditorial Material

Dosyalar

Koleksiyonlar

WOS